In the present study, genistein and diethylstilbestrol inhibited BC cell growth and decreased PTGES3 expression at the protein and mRNA levels, indicating that the antitumor effects of these drugs were closely related to PTGES3. However, the potential underlying mechanisms should be explored in further experiments. This evidence concerns the gene PTGES3 and breast cancer.